Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination of Rectal Indomethacin and Pancreatic Duct Stenting Versus Indomethacin Alone in Preventing Post-ERCP Pancreatitis in Patients With Difficult Cannulation

NCT04340687 is registered in ClinicalTrials.gov with Air Force Military Medical University, China as lead sponsor.

NCT NCT04340687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04340687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination of Rectal Indomethacin and Pancreatic Duct Stenting Versus Indomethacin Alone in Preventing Post-ERCP Pancreatitis in Patients With Difficult Cannulation
Lead sponsor
Air Force Military Medical University, China
Phase
Observational
Overall status
Completed
Start date
January 1, 2020
Completion date
March 1, 2020
Enrollment
664 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy